ArticleFrontiers in immunology2022

Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.

Jeonghyeon Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.